Back to Search
DR. DANIEL CLARKE-PEARSON MD
MD
Gynecologic Oncology Physician
NPI: 1487742888Individual
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
23261(NC)
Research & Publications (20)
Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression.
PMID 12517661·Obstet Gynecol·2003
8-other
Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer.
PMID 11579118·J Clin Oncol·2001
3-trial
Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists.
PMID 19407573·Int J Gynecol Cancer·2009
8-other
Cost benefit of intermittent pneumatic compression for venous thromboembolism prophylaxis in general surgery.
PMID 19078913·Int Angiol·2008
8-other
A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study.
PMID 18482765·Gynecol Oncol·2008
3-trial
Combination prophylaxis for thromboembolism prevention among gynecologic oncology patients perioperatively.
PMID 18294678·Gynecol Oncol·2008
8-other
Outcomes in surgical stage I uterine papillary serous carcinoma.
PMID 17355889·Gynecol Oncol·2007
4-observational
Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer.
PMID 17380438·Int J Clin Oncol·2007
4-observational
Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study.
PMID 17906207·J Clin Oncol·2007
3-trial
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
PMID 17968019·J Clin Oncol·2007
1-meta
Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
PMID 17502627·J Clin Oncol·2007
3-trial
The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
PMID 17014898·Gynecol Oncol·2007
8-other
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
PMID 17137617·Gynecol Oncol·2007
8-other
Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep venous thrombosis.
PMID 17599396·Gynecol Oncol·2007
8-other
The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
PMID 17688923·Gynecol Oncol·2007
4-observational
Pulmonary embolism after major abdominal surgery in gynecologic oncology.
PMID 16816081·Obstet Gynecol·2006
8-other
Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
PMID 16368440·Gynecol Oncol·2006
3-trial
Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
PMID 16406063·Gynecol Oncol·2006
8-other
Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma.
PMID 16754599·Int J Hyperthermia·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 101 MANNING DR
CHAPEL HILL, NC 27599 - Phone
- (919) 966-4996
Quick Facts
- NPI
- 1487742888
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile